Imron Aly is an experienced IP litigator at ArentFox Schiff. Working with industry-leading clients in pharma and tech, Aly is viewed as a go-to trial lawyer specifically regarding patent infringement. Aly works on a range of IP matters including medical devices, financial trading systems and computer business methods, often dealing with highly complex cross-jurisdictional work.
Intellectual property: contentious in United States
ArentFox Schiff
Principaux clients
Nexus Pharmaceuticals, Inc.
Fresenius Kabi USA, LLC
Alkem Laboratories Ltd.
Gland Pharma Ltd.
Hikma Pharmaceuticals
Maia Pharma
Principaux dossiers
- Leveraged claim construction to exploit potential non-infringement arguments in defense of some of the asserted claims to obtain approval for and market a generic version of an intravenous drug.
- Successfully argued that claim terms were not properly defined therefore winning a judgement of invalidity, helping Nexus pursue a generic version for patients.
TottisLaw
Kevin Tottis, founding partner of TottisLaw, has first‑chaired numerous complex commercial and IP cases, representing diverse clients such as manufacturers, consumer brands, educational institutions, and nonprofits. A seasoned appellate advocate, Tottis has successfully led high-impact IP matters, including dramatic rights arbitration, complex trademark disputes and briefing before the Supreme Court on key copyright issues, and is also sought-after as an arbitrator.